Holen Sie sich die Stockscreener-App
148.40
0.27%
-0.27
Handel nachbörslich:
148.40
Schlusskurs vom Vortag:
$148.67
Offen:
$146.16
24-Stunden-Volumen:
858.82K
Relative Volume:
0.97
Marktkapitalisierung:
$8.35B
Einnahmen:
$633.51M
Nettoeinkommen (Verlust:
$-8.10M
KGV:
-478.71
EPS:
-0.31
Netto-Cashflow:
$131.26M
1W Leistung:
+1.60%
1M Leistung:
+30.58%
6M Leistung:
+16.51%
1J Leistung:
+3.65%
1-Tages-Spanne:
$145.50
$150.85
1-Wochen-Bereich:
$143.47
$153.02
52-Wochen-Spanne:
$102.97
$182.52
Repligen Corp Stock (RGEN) Company Profile
Firmenname
Repligen Corp
Sektor
Telefon
(781) 449-9560
Adresse
41 SEYON STREET, WALTHAM, MA
Vergleichen Sie RGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
148.40 | 8.36B | 633.51M | -8.10M | 131.26M | -0.31 |
|
ISRG
Intuitive Surgical Inc
|
436.39 | 156.20B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
188.35 | 53.50B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
270.15 | 39.84B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
74.08 | 35.89B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
261.26 | 18.87B | 2.96B | 487.70M | 344.00M | 6.6758 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-01 | Eingeleitet | HSBC Securities | Buy |
| 2025-09-22 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-07-22 | Fortgesetzt | Stephens | Overweight |
| 2025-06-24 | Eingeleitet | Barclays | Overweight |
| 2025-04-29 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | Eingeleitet | Evercore ISI | In-line |
| 2025-02-10 | Eingeleitet | TD Cowen | Buy |
| 2024-12-17 | Eingeleitet | Canaccord Genuity | Hold |
| 2024-11-14 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-26 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-06-18 | Eingeleitet | Guggenheim | Neutral |
| 2023-12-04 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-07-20 | Eingeleitet | Wells Fargo | Overweight |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-03-28 | Eingeleitet | The Benchmark Company | Buy |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2021-10-14 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-30 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-07 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-23 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-11-01 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-28 | Bestätigt | First Analysis Sec | Outperform |
| 2019-08-23 | Fortgesetzt | Stephens | Overweight |
| 2019-07-22 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | Hochstufung | CL King | Neutral → Buy |
| 2018-11-12 | Herabstufung | CL King | Buy → Neutral |
| 2018-09-26 | Eingeleitet | H.C. Wainwright | Neutral |
| 2017-12-08 | Eingeleitet | Citigroup | Buy |
| 2017-12-05 | Eingeleitet | JP Morgan | Overweight |
| 2017-11-13 | Eingeleitet | CL King | Buy |
| 2017-10-02 | Hochstufung | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | Eingeleitet | William Blair | Outperform |
| 2017-02-13 | Hochstufung | Piper Jaffray | Neutral → Overweight |
Alle ansehen
Repligen Corp Aktie (RGEN) Neueste Nachrichten
Tools to monitor Repligen Corporation recovery probabilityQuarterly Market Review & Momentum Based Trading Signals - newser.com
Does Repligen Corporation stock trade at a discount to peersMarket Risk Summary & Safe Capital Growth Trade Ideas - newser.com
Historical volatility pattern of Repligen Corporation visualizedIPO Watch & Expert Curated Trade Ideas - newser.com
Using data tools to time your Repligen Corporation exit2025 Technical Patterns & Weekly Momentum Picks - newser.com
Repligen Corporation (RGEN) Stock Analysis: An Investor’s Guide to a 23.4% Potential Upside - DirectorsTalk Interviews
Repligen (NASDAQ:RGEN) Rating Increased to Buy at Wall Street Zen - Defense World
Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know - Barchart.com
Hollow Fiber Filtration Market Is Booming Worldwide 2025-2032 | - openPR.com
Is Repligen (RGEN) The Best Healthcare Stock to Buy Now? - Insider Monkey
Repligen Corporation’s volatility index tracking explainedWall Street Watch & Verified Trade Idea Suggestions - newser.com
Can technical indicators confirm Repligen Corporation’s reversal - newser.com
Repligen Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Repligen’s SWOT analysis: bioprocessing leader faces growth challenges - Investing.com
Evercore ISI Issues Positive Forecast for Repligen (NASDAQ:RGEN) Stock Price - Defense World
RGEN: Evercore ISI Group Maintains "Outperform" Rating, Raises P - GuruFocus
Evercore Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $175 - 富途牛牛
Repligen (RGEN): Assessing Valuation Following HSBC’s Positive Coverage and Renewed Biotech Optimism - simplywall.st
Short interest data insights for Repligen CorporationMarket Volume Report & Safe Entry Point Alerts - newser.com
Is Repligen Corporation stock affected by interest rate hikesGlobal Markets & AI Forecast for Swing Trade Picks - newser.com
111 Capital Purchases New Holdings in Repligen Corporation $RGEN - MarketBeat
What indicators show strength in Repligen Corporation2025 Historical Comparison & Weekly Setup with High ROI Potential - newser.com
Can New Analyst Attention on RGEN Reveal the True Strength of Repligen's Bioprocessing Edge? - simplywall.st
Is Repligen’s Recent 18% Price Surge Justified After Broad Biotech Rally? - Yahoo Finance
Why Investors Shouldn't Be Surprised By Repligen Corporation's (NASDAQ:RGEN) 28% Share Price Surge - simplywall.st
Why Repligen Corporation stock attracts global investorsMarket Sentiment Report & Real-Time Volume Analysis - newser.com
Key metrics from Repligen Corporation’s quarterly dataWeekly Trade Report & Community Shared Stock Ideas - newser.com
Why Repligen Corporation stock is a must watch in 2025July 2025 Movers & Accurate Intraday Trading Signals - newser.com
Published on: 2025-10-03 00:54:45 - newser.com
Applying big data sentiment scoring on Repligen Corporation2025 Risk Factors & Reliable Breakout Forecasts - newser.com
GAMMA Investing LLC Sells 132 Shares of Repligen Corporation $RGEN - Defense World
Repligen (RGEN) Poised for Rebound Amid Market Shifts - GuruFocus
What 8 Analyst Ratings Have To Say About Repligen - Benzinga
Best Manufacturing Stocks To Follow TodayOctober 1st - MarketBeat
Repligen (RGEN) Receives "Buy" Rating from HSBC with Target Pric - GuruFocus
Why Is Repligen (RGEN) Stock Soaring Today - Yahoo Finance
Repligen (RGEN) Gains Momentum with HSBC's Buy Rating and Strong Growth Outlook - GuruFocus
HSBC initiates coverage on Repligen stock with Buy rating, $150 target - Investing.com
Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know - Yahoo Finance
Fifth Third Bancorp Reduces Stock Position in Repligen Corporation $RGEN - Defense World
What analysts say about Repligen Corporation RGN stockGlobal Trade Effects & Free Popular Stock Picks Selection - earlytimes.in
Is Repligen Corporation (RGN) stock bottoming after sell offJuly 2025 Drop Watch & Comprehensive Market Scan Insights - newser.com
How Repligen Corporation stock performs in interest rate cycles2025 Top Decliners & Safe Capital Growth Trade Ideas - newser.com
What data driven models say about Repligen Corporation’s future2025 Performance Recap & Comprehensive Market Scan Insights - newser.com
Finanzdaten der Repligen Corp-Aktie (RGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Repligen Corp-Aktie (RGEN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Hunt Anthony | Director |
Sep 10 '25 |
Sale |
120.52 |
29,111 |
3,508,389 |
100,743 |
0.91%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):